Antianginal drugs--a review.
D000328:Adult; D000628:Aminophylline / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D002319:Cardiovascular System / Q000187:drug effects; D002346:Carotid Sinus / Q000294:innervation; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000503:physiopathology; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D009474:Neurons / Q000187:drug effects; D009566:Nitrates / Q000494:pharmacology; D009573:Nitrites / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D006993:Hypnotics and Sedatives; D009566:Nitrates; D009573:Nitrites; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D000628:Aminophylline; D004176:Dipyridamole; D011433:Propranolol; D010208:Papaverine